🔗 Share this article

As the US proceeds with unprecedented changes to its immunization schedules, one figure has surfaced in a surprising turn: Dr. Tracy Beth Høeg, a Danish American sports medicine doctor and epidemiologist who rose to prominence by questioning COVID-19 vaccinations throughout the pandemic and has focused upon potential deaths following COVID-19 vaccination in her short position at the FDA.

Proposed Overhauls to Childhood Immunization Schedule

Agency leaders planned to announce major revisions to the childhood vaccination calendar recently, synchronizing the US with the Danish immunization schedule, according to reports – a significant shift that would place the US out of alignment with many the global community with no evidence for improved outcomes. The planned update has been pushed back until the next year.

Rather than the director of the vaccine center, Høeg is set to address the audience at the event. She was recently named temporary leader of the FDA’s CDER, the fifth individual to lead the office this calendar year.

Consolidating Power at the Agency

The acting appointment could signify a closer partnership between the pharmaceutical and vaccine divisions as Høeg and Dr. Prasad strengthen their influence at the FDA – and it signals a renewed priority upon rolling back previously authorized immunizations at the FDA.

Dr. Høeg has often pushed for halting some childhood shot schedules in the US to become more similar to the Danish model, a society with nationalized medicine and a number of inhabitants roughly the size of Wisconsin’s.

To date comments, she has persisted in emphasizing on vaccines – usually the responsibility of Dr. Prasad, head of the FDA’s vaccine center – as opposed to medication approval.

Concerns Over Qualifications

The appointee has no obvious experience in medication creation, regulation or management, which has been typical for previous heads of the biologics center. She has worked at the FDA as a senior adviser to the agency head and the vaccine center since spring.

“It seems she lacks to have the necessary background” for overseeing the drug-regulation department, said Dr. Jonathan Howard. “She has not conducted a scientific study. She is not versed in running a major agency. She lacks background in industry regulation.”

Former heads of CBER would “be deeply familiar with regulatory frameworks and the research of medication creation”, noted a former acting FDA commissioner. “Objectively, she doesn’t have the sort of resume that previous people who led CBER have had.”

CDER has an immense workload at the FDA, the former commissioner stated.

“Many people just pays attention on the new drug program, but the generic program authorizes numerous generic medications. There’s a biosimilars division, non-prescription drug unit and so forth, and all of those have to be managed,” she noted. “The thing you neglect, that’s the thing that I always told people is going to come back to haunt you.”

Furthermore, a major management component to the role, which supervises over 5,000 employees. “It’s a enormous management job, if you do it right,” she said.

Official Statement and Controversial Initiatives

When asked about questions about Høeg’s qualifications and whether this assignment represents greater collaboration among FDA leaders on immunizations, a spokesperson responded that the “questions are based on flawed presumptions”.

“Her experience matches the duties of her position,” the spokesperson said, citing the months Dr. Høeg spent advising the FDA commissioner on “pharmaceutical safety and regulatory science, including predictive safety algorithms and immunization monitoring”.

As acting director, Høeg assumes responsibility for the agency head's recently launched expedited review system, a disputed rapid medication authorization process that reportedly troubled her predecessors. “How are these drugs being picked for this voucher program? Who is making the choices?” Howard asked. “There is a lot of secrecy going on at the FDA right now.”

Broadly speaking, he remarked, “the agency appears to be shifting towards laxer rules of most medications, except for shots.”

Documented History on Vaccines

Concerning vaccines, Høeg has a more documented, if troubling, history, Howard observe. She authored a research paper using unverified public submissions to estimate the incidence of heart inflammation after COVID-19 immunization. She counseled the state of Florida chief medical officer Joseph Ladapo, who was said to have changed statistics to indicate COVID-19 vaccines are pose a greater threat than they are.

Part of her “policy goals” for the new federal leadership included revising guidelines for new vaccines and halting “optional” vaccines, she stated post-election on a podcast. At the agency, Dr. Høeg has according to sources proposed preventing young men from receiving Covid vaccinations.

“She’s an thorough dogmatist who commences with her conclusions and works backwards to retrofit the data in a extremely deceptive, fraudulent manner,” Dr. Howard stated.

Gaining Influence and a “Campaign of Retribution”

Høeg became part of fellow dissenters, {like|